Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
about
Aspartame: A Safety Evaluation Based on Current Use Levels, Regulations, and Toxicological and Epidemiological StudiesImproving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animals.Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs.Risk assessment in the genomic era.Kinetic Modeling Reveals the Roles of Reactive Oxygen Species Scavenging and DNA Repair Processes in Shaping the Dose-Response Curve of KBrO₃-Induced DNA Damage.A tiered approach to systemic toxicity testing for agricultural chemical safety assessment.Science, politics, and health in the brave new world of pharmaceutical carcinogenic risk assessment: technical progress or cycle of regulatory capture?An industry perspective on the utility of short-term carcinogenicity testing in transgenic mice in pharmaceutical development.Historical perspective on the use of animal bioassays to predict carcinogenicity: evolution in design and recognition of utility.A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.Cloning of the 5' upstream region of the rat p16 gene and its role in silencing.Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.Alternative Multiorgan Initiation-Promotion Assay for Chemical Carcinogenesis in the Wistar Rat.
P2860
Q23901998-C556F627-65D8-4320-9088-980B4688ABB0Q35244653-0AFE9729-6137-4D3B-9BCE-E13D365CE81AQ35621829-EBA7BEDC-D7E2-406D-8F84-83AC82D2A329Q35812472-C32B7D0B-E842-4347-8F99-B3E42FBE1AA8Q36089306-BE2FDF25-9C77-4DBA-A308-CD1452BEF777Q36481766-0B2E4B8F-7E4C-469D-9BF9-8C2D7AEFD3E2Q37187425-0EFB9D60-06DD-4188-B6C4-26460D168EE9Q37628343-34F4626D-D5B7-4879-9265-CB3BEDDF9E54Q37857848-1ECA5F87-67A8-4EFC-B4B9-5A1E6757D734Q38233531-F20F4AFB-AB07-4210-BCCA-20227DA2A241Q40692246-1C6A10F8-EAA9-4271-A156-1A7673610767Q48130096-6F381CE8-2FEC-4078-A2CA-44CCE868E131Q51118711-6FF48170-834A-4433-A164-0F3FE1BE4CE6
P2860
Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alternative models for carcino ...... nce evaluations across models.
@ast
Alternative models for carcino ...... nce evaluations across models.
@en
type
label
Alternative models for carcino ...... nce evaluations across models.
@ast
Alternative models for carcino ...... nce evaluations across models.
@en
prefLabel
Alternative models for carcino ...... nce evaluations across models.
@ast
Alternative models for carcino ...... nce evaluations across models.
@en
P1476
Alternative models for carcino ...... nce evaluations across models.
@en
P2093
P304
P356
10.1080/019262301753178609
P407
P478
P577
2001-01-01T00:00:00Z